Immediate Impact

2 from Science/Nature 55 standout
Sub-graph 1 of 23

Citing Papers

Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
2025 Standout
Understanding and targeting resistance mechanisms in cancer
2023 Standout
8 intermediate papers

Works of Daniel B. Kennedy being referenced

Rituximab Plus Chlorambucil As First-Line Treatment for Chronic Lymphocytic Leukemia: Final Analysis of an Open-Label Phase II Study
2014
Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1
2005
and 4 more

Author Peers

Author Last Decade Papers Cites
Daniel B. Kennedy 184 140 155 143 11 415
Julie Hessler 66 26 285 10 15 433
Valia S. Lestou 49 22 112 120 17 426
Christian Helms Jørgensen 40 53 17 49 23 479
Margrét Sigurðardóttir 29 57 88 179 24 395
Gayatri Sreenivasan 79 112 177 113 20 439
M. F. Avril 50 113 69 82 10 382
Therese R. Giambarresi 103 63 112 51 9 484
Georg Fertig 18 94 28 268 20 490
Christopher Jenkins 108 84 161 175 11 449
Steven Fabian 22 22 32 206 12 385

All Works

Loading papers...

Rankless by CCL
2026